Giampaolo Tortora
Giampaolo Tortora
Medical Oncology- Fondazione Policlinico Universitario Gemelli-IRCCS Roma
Verified email at policlinicogemelli.it
Title
Cited by
Cited by
Year
EGFR antagonists in cancer treatment
F Ciardiello, G Tortora
New England Journal of Medicine 358 (11), 1160-1174, 2008
21682008
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
AV Biankin, N Waddell, KS Kassahn, MC Gingras, LB Muthuswamy, ...
Nature 491 (7424), 399-405, 2012
15622012
Whole genomes redefine the mutational landscape of pancreatic cancer
N Waddell, M Pajic, AM Patch, DK Chang, KS Kassahn, P Bailey, ...
Nature 518 (7540), 495-501, 2015
15612015
Genomic analyses identify molecular subtypes of pancreatic cancer
P Bailey, DK Chang, K Nones, AL Johns, AM Patch, MC Gingras, ...
Nature 531 (7592), 47-52, 2016
15272016
A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor
F Ciardiello, G Tortora
Clinical Cancer Research 7 (10), 2958-2970, 2001
12912001
Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor
F Ciardiello, R Caputo, R Bianco, V Damiano, G Pomatico, S De Placido, ...
Clinical Cancer Research 6 (5), 2053-2063, 2000
12122000
Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor
F Ciardiello, R Caputo, R Bianco, V Damiano, G Fontanini, S Cuccato, ...
Clinical cancer research 7 (5), 1459-1465, 2001
7612001
ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinases
F Carlomagno, D Vitagliano, T Guida, F Ciardiello, G Tortora, G Vecchio, ...
Cancer research 62 (24), 7284-7290, 2002
6522002
Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer
G Di Lorenzo, G Tortora, FP D’Armiento, G De Rosa, S Staibano, ...
Clinical Cancer Research 8 (11), 3438-3444, 2002
5312002
Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense …
F Ciardiello, R Bianco, V Damiano, G Fontanini, R Caputo, G Pomatico, ...
Clinical Cancer Research 6 (9), 3739-3747, 2000
4992000
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas
Y Jiao, TM Pawlik, RA Anders, FM Selaru, MM Streppel, DJ Lucas, ...
Nature genetics 45 (12), 1470-1473, 2013
4562013
nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: long-term survival from a phase III trial
D Goldstein, RH El-Maraghi, P Hammel, V Heinemann, V Kunzmann, ...
JNCI: Journal of the National Cancer Institute 107 (2), 2015
4422015
Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor …
F Ciardiello, R Caputo, V Damiano, R Caputo, T Troiani, D Vitagliano, ...
Clinical Cancer Research 9 (4), 1546-1556, 2003
4312003
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
T Golan, P Hammel, M Reni, E Van Cutsem, T Macarulla, MJ Hall, ...
New England Journal of Medicine 381 (4), 317-327, 2019
4262019
Whole-genome landscape of pancreatic neuroendocrine tumours
A Scarpa, DK Chang, K Nones, V Corbo, AM Patch, P Bailey, RT Lawlor, ...
Nature 543 (7643), 65-71, 2017
4092017
Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225
F Ciardiello, R Bianco, V Damiano, S De Lorenzo, S Pepe, S De Placido, ...
Clinical Cancer Research 5 (4), 909-916, 1999
4021999
Differential activity of nivolumab, pembrolizumab and MPDL3280A according to the tumor expression of programmed death-ligand-1 (PD-L1): sensitivity analysis of trials in …
L Carbognin, S Pilotto, M Milella, V Vaccaro, M Brunelli, A Caliò, ...
PloS one 10 (6), e0130142, 2015
3912015
Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth …
F Ciardiello, R Bianco, R Caputo, R Caputo, V Damiano, T Troiani, ...
Clinical Cancer Research 10 (2), 784-793, 2004
3892004
A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer
M De Laurentiis, G Arpino, E Massarelli, A Ruggiero, C Carlomagno, ...
Clinical cancer research 11 (13), 4741-4748, 2005
3812005
Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer
J Tabernero, E Van Cutsem, E Díaz-Rubio, A Cervantes, Y Humblet, ...
Journal of clinical oncology 25 (33), 5225-5232, 2007
3712007
The system can't perform the operation now. Try again later.
Articles 1–20